Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 9Ovarian Neoplasms 6Neoplasms 6Liposarcoma 4Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Neoplasms by Site 2Uterine Neoplasms 1Skin Diseases 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Diseases 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Liver Diseases 1Liposarcoma, Myxoid 1Hepatic Insufficiency 1Genital Diseases, Female 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Endocrine Gland Neoplasms 1Carcinoma 1Breast Diseases 1Adnexal Diseases 1

Interventions

Prednisone 102enzalutamide 74Docetaxel 72Abiraterone Acetate 67Leuprolide 47acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 45abiraterone 37apalutamide 28Prednisolone 27bicalutamide 26Zoledronic Acid 24pembrolizumab 22Goserelin 22radium Ra 223 dichloride 21darolutamide 21Triptorelin Pamoate 17cabazitaxel 15Androgen Antagonists 15sipuleucel-T 13luprolide acetate gel depot 12Injections 12Dexamethasone 12olaparib 11gallium 68 PSMA-11 10Mitoxantrone 10Pluvicto 9Ipilimumab 9Dutasteride 9Cyclophosphamide 9relugolix 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Prostatic Neoplasms × Trabectedin × Clear all
NCT00072670 2014-04-08

A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
59 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡